Who
Alison Mosca
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Clene.
In numbers
- Trades disclosed
- 62
- Buys
- 4
- Sells
- 0
- Bought
- $3.2M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Apr 2021
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | CLNN CleneBiotechnology | SEC FORM 4 Code A | $650K198,171 at $3.28 | filing |
| 16 Sep 2026filed 18 Sep 2026 | CLNN CleneBiotechnology | SEC FORM 4 Code A | $650K198,171 at $3.28 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,872 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,872 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,861 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,861 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,201 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,201 at $0.00 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN CleneBiotechnology | SEC FORM 4 Code A | $100K16,667 at $6.00 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,667 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,667 | filing |
| 13 Jan 2026filed 13 Jan 2026 | CLNN CleneBiotechnology | SEC FORM 4 Code A | $100K16,667 at $6.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | CLNN CleneBiotechnology | SEC FORM 4 Code J | —57,219 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code J | —57,219 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code J | —57,219 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code J | —57,219 at $0.00 | filing |
News
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALSCLNN · manilatimes.net · 19 Oct 2026Head to Head Survey: Shineco (NASDAQ:SISI) vs. Clene (NASDAQ:CLNN)CLNN · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Alison Mosca; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.